Diagnostic and therapy of the complex regional pain syndrome
Our scientific studies of biological samples derived from CRPS patients demonstrated for the first time that the onset of CRPS is caused by autoantibodies against specific receptors, which activate these receptors and elicit, in the context of an autoimmune disease, neuronal inflammatory reactions. <br>
Specific ligands a patent is applied for are now provided. The ligands interact with these autoantibodies in the blood, thereby neutralizing them considerably. Bound for example to column material, the specific ligands can be employed for the therapy as well as the diagnosis of the complex regional pain syndrome, and even be used for prophylaxis.<br> As standard technology for diagnosis, in particular immunofluorescence has proven to be of value. In general, also other applications are possible.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
A universal framework for spatial biology
SpatialData is a freely accessible tool to unify and integrate data from different omics technologies accounting for spatial information, which can provide holistic insights into health and disease. Biological processes…
How complex biological processes arise
A $20 million grant from the U.S. National Science Foundation (NSF) will support the establishment and operation of the National Synthesis Center for Emergence in the Molecular and Cellular Sciences (NCEMS) at…
Airborne single-photon lidar system achieves high-resolution 3D imaging
Compact, low-power system opens doors for photon-efficient drone and satellite-based environmental monitoring and mapping. Researchers have developed a compact and lightweight single-photon airborne lidar system that can acquire high-resolution 3D…
